Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: Treprostinil is a potent DP1 and EP2 agonistBrendan J.R. Whittle, Lucie H. Clapp, Adam M. Silverstein et al.|Biochemical Pharmacology|2012Cited by 166
Prostanoid EP2 Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle CellsJigisha Patel, Lucie H. Clapp, Robin J. McAnulty et al.|International Journal of Molecular Sciences|2018Cited by 34
Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veinsNelson N. Orie, Lucie H. Clapp, A Ledwozyw et al.|Prostaglandins & Other Lipid Mediators|2013Cited by 27
Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertensionLei Shen, Lucie H. Clapp, Jigisha Patel et al.|Biochemical Pharmacology|2019Cited by 10
Ep2 Receptors Play A Key Role In Mediating The Anti-Proliferative Activity Of Treprostinil In Smooth Muscle Cells Derived From The Lungs Of Pulmonary Hypertensive PatientsJitesh A. Patel, Lucie H. Clapp, Brendan J.R. Whittle et al.|UCL Discovery (University College London)|2015Cited by 2